Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA.
University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.
Microbiome. 2022 Apr 19;10(1):64. doi: 10.1186/s40168-022-01242-x.
Recent evidence implicates microbial sulfidogenesis as a potential trigger of colorectal cancer (CRC), highlighting the need for comprehensive knowledge of sulfur metabolism within the human gut. Microbial sulfidogenesis produces genotoxic hydrogen sulfide (HS) in the human colon using inorganic (sulfate) and organic (taurine/cysteine/methionine) substrates; however, the majority of studies have focused on sulfate reduction using dissimilatory sulfite reductases (Dsr).
Here, we show that genes for microbial sulfur metabolism are more abundant and diverse than previously observed and are statistically associated with CRC. Using ~ 17,000 bacterial genomes from publicly available stool metagenomes, we studied the diversity of sulfur metabolic genes in 667 participants across different health statuses: healthy, adenoma, and carcinoma. Sulfidogenic genes were harbored by 142 bacterial genera and both organic and inorganic sulfidogenic genes were associated with carcinoma. Significantly, the anaerobic sulfite reductase (asr) genes were twice as abundant as dsr, demonstrating that Asr is likely a more important contributor to sulfate reduction in the human gut than Dsr. We identified twelve potential pathways for reductive taurine metabolism and discovered novel genera harboring these pathways. Finally, the prevalence of metabolic genes for organic sulfur indicates that these understudied substrates may be the most abundant source of microbially derived HS.
Our findings significantly expand knowledge of microbial sulfur metabolism in the human gut. We show that genes for microbial sulfur metabolism in the human gut are more prevalent than previously known, irrespective of health status (i.e., in both healthy and diseased states). Our results significantly increase the diversity of pathways and bacteria that are associated with microbial sulfur metabolism in the human gut. Overall, our results have implications for understanding the role of the human gut microbiome and its potential contributions to the pathogenesis of CRC. Video abstract.
最近的证据表明,微生物硫酸盐还原作用可能是引发结直肠癌(CRC)的一个潜在因素,这凸显了人们对人类肠道内硫代谢进行全面了解的必要性。微生物硫酸盐还原作用利用无机(硫酸盐)和有机(牛磺酸/半胱氨酸/蛋氨酸)底物在人类结肠中产生遗传毒性的硫化氢(HS);然而,大多数研究都集中在使用异化亚硫酸盐还原酶(Dsr)进行硫酸盐还原上。
在这里,我们表明,微生物硫代谢基因比以前观察到的更加丰富多样,并且与 CRC 具有统计学上的关联。我们使用来自公开可用的粪便宏基因组的约 17000 个细菌基因组,研究了 667 名不同健康状况(健康、腺瘤和癌)参与者的硫代谢基因多样性。硫化基因存在于 142 个细菌属中,有机和无机硫化基因都与癌有关。重要的是,厌氧亚硫酸盐还原酶(asr)基因的丰度是 Dsr 的两倍,这表明 Asr 可能是人类肠道中硫酸盐还原的更重要贡献者。我们确定了 12 种潜在的还原牛磺酸代谢途径,并发现了含有这些途径的新属。最后,有机硫代谢基因的流行表明,这些研究不足的底物可能是微生物衍生 HS 的最丰富来源。
我们的研究结果显著扩展了对人类肠道中微生物硫代谢的认识。我们表明,无论健康状况如何(即健康和患病状态),人类肠道中的微生物硫代谢基因比以前已知的更为普遍。我们的结果显著增加了与人类肠道微生物硫代谢相关的途径和细菌的多样性。总的来说,我们的研究结果对于理解人类肠道微生物组的作用及其对 CRC 发病机制的潜在贡献具有重要意义。视频摘要。